Sensorion announced the appointment of Otmane Boussif, a senior leader with extensive experience in managing global Chemistry, Manufacturing and Controls organizations, as Chief Technical Officer, effective August 1, 2021. Dr. Boussif joins from Novartis, where he held a number of senior roles, including Global Head of Cell and Gene Therapy Technical Development and Global Head of Early Phase Development. Dr. Boussif brings considerable expertise in CMC development and implementation as well as a strong background in developing different biological modalities. In his new role, Dr. Boussif will oversee all the technical operations and CMC functions at Sensorion.